Are required pre-treatment dental evaluations in the osteoporosis population a barrier to antiresorptive therapies?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42326739.
- Also identified by DOI 10.1016/j.bonr.2026.101926 and PMC identifier 13280135.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Dental evaluation is recommended before bisphosphonates (BPs) initiation because of the rare but serious risk of medication-related osteonecrosis of the jaw. In this context, the objective of this study was to assess the prevalence of the indication for dental care (DC) prior to BPs initiation for osteoporosis (OP). Monocentric retrospective study between January 2019 and August 2022. Inclusion criteria: patients requiring OP treatment with dental evaluation (panoramic dental X-ray (PD) and dental teleconsultation). Exclusion criteria: PD without tele-dental evaluation, BPs for other indications than OP, OP not treated with BPs. Collected data: demographic characteristics, medical history, bone status, conclusions of tele-dental expertise. 130 patients were included, mean age of 74.3 years (±12.2), 102 were women. DC was required for 95/130 patients (DC group). In the DC group, 77/95 required surgical DC, 35/77 completed the surgical DC, and 30/35 initiated BPs. 18/95 patients required non-surgical DC, 6/18 completed the DC, and 5/6 initiated BPs. BPs were initiated in 35/95 (36,8%) patients in the DC group and 29/35 (82,9%) in the non-DC group. The prevalence of DC required before BPs initiation in OP patients is high and have a negative impact on the effective implementation of OP treatment. These results emphasize the need for healthcare policies aimed at improving access to DC and the necessity for clear guidelines regarding DC management in the context of BPs therapy.